Publication:
Use of mycophenolate mofetil in kidney transplant recipients with viral hepatitis infection: Is it justified?

Simple item page
dc.contributor.authorVasant Sumethkulen_US
dc.contributor.authorA. Ingsathiten_US
dc.contributor.authorP. Leelasa-Nguanen_US
dc.contributor.authorS. Jirasirithamen_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-07-24T03:02:48Z
dc.date.available2018-07-24T03:02:48Z
dc.date.issued2002-12-01en_US
dc.identifier.citationTransplantation Proceedings. Vol.34, No.8 (2002), 3217-3219en_US
dc.identifier.doi10.1016/S0041-1345(02)03697-7en_US
dc.identifier.issn00411345en_US
dc.identifier.other2-s2.0-0036905388en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/20266
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0036905388&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleUse of mycophenolate mofetil in kidney transplant recipients with viral hepatitis infection: Is it justified?en_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0036905388&origin=inwarden_US

Files

Collections

Scopus 2001-2005